Epidermal growth factor does not cross the blood-brain barrier

Area of Science:

• Neuroscience
• Physiology
• Biochemistry

Background:

• The blood-brain barrier (BBB) tightly regulates the passage of substances into the brain.
• Understanding the transport of growth factors like epidermal growth factor (EGF) across the BBB is crucial for neurological research.

Purpose of the Study:

• To quantify the passage of epidermal growth factor (EGF) across the blood-brain barrier (BBB).
• To determine if EGF transport exceeds levels predicted by its molecular size.

Main Methods:

• Intravenous injection of 125I-labeled EGF into adult rats.
• Measurement of 125I-EGF distribution in blood and cerebrospinal fluid (CSF) over several hours.
• Calculation of the EGF equilibrium concentration in CSF relative to blood.

Main Results:

• A stable distribution of intact 125I-EGF in CSF was observed between 2 to 6 hours post-injection.
• The CSF concentration of EGF was approximately 1/500th of the blood concentration.
• This equilibrium value is lower than that reported for BBB-impermeable compounds like inulin.

Conclusions:

• 125I-EGF is detectable in the CSF, confirming some level of passage across the BBB.
• The rate and quantity of EGF passage do not exceed expectations based on its molecular size.
• EGF transport across the BBB appears to be primarily governed by passive diffusion rather than specific active transport mechanisms.